These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8577940)

  • 1. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis.
    Dupouy V; Zajac JM
    Regul Pept; 1995 Nov; 59(3):349-56. PubMed ID: 8577940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus.
    Dupouy V; Zajac JM
    Eur J Pharmacol; 1997 Jul; 330(2-3):129-37. PubMed ID: 9253945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide FF, pain and analgesia.
    Roumy M; Zajac JM
    Eur J Pharmacol; 1998 Mar; 345(1):1-11. PubMed ID: 9593588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C; Jhamandas K; Sutak M; Zajac JM
    Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs.
    Gouardères C; Sutak M; Zajac JM; Jhamandas K
    Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide.
    Gelot A; Mazarguil H; Dupuy P; Francés B; Gouardères C; Roumy M; Zajac JM
    Eur J Pharmacol; 1998 Aug; 354(2-3):167-72. PubMed ID: 9754917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
    Million M; Fioramonti J; Gicquel S; Zajac JM; Bueno L
    J Pharmacol Exp Ther; 1993 Apr; 265(1):96-102. PubMed ID: 8474035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain.
    Rothman RB; Brady LS; Xu H; Long JB
    Peptides; 1993; 14(6):1271-7. PubMed ID: 8134310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.
    Quelven I; Roussin A; Burlet-Schiltz O; Gouardères C; Tafani JA; Mazarguil H; Zajac JM
    Eur J Pharmacol; 2002 Aug; 449(1-2):91-8. PubMed ID: 12163111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
    Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM
    Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modulation of mu- and delta-opioid antinociception by neuropeptide FF receptors in young mice.
    Desprat C; Zajac JM
    Neuropeptides; 1997 Feb; 31(1):1-7. PubMed ID: 9574828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors.
    Raffa RB; Kim A; Rice KC; de Costa BR; Codd EE; Rothman RB
    Peptides; 1994; 15(3):401-4. PubMed ID: 7937312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic actions of neuropeptide FF in the rat parabrachial nucleus: interactions with opioid receptors.
    Chen X; Zidichouski JA; Harris KH; Jhamandas JH
    J Neurophysiol; 2000 Aug; 84(2):744-51. PubMed ID: 10938301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide FF exerts pro- and anti-opioid actions in the parabrachial nucleus to modulate food intake.
    Nicklous DM; Simansky KJ
    Am J Physiol Regul Integr Comp Physiol; 2003 Nov; 285(5):R1046-54. PubMed ID: 14557236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
    Fang Q; Jiang TN; Li N; Han ZL; Wang R
    Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects.
    Gicquel S; Mazarguil H; Allard M; Simonnet G; Zajac JM
    Eur J Pharmacol; 1992 Nov; 222(1):61-7. PubMed ID: 1468500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat.
    Oberling P; Stinus L; Le Moal M; Simonnet G
    Peptides; 1993; 14(5):919-24. PubMed ID: 8284268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of alpha 2-adrenergic and mu-opioid spinal antinociception by neuropeptide FF.
    Kontinen VK; Kalso EA
    Peptides; 1995; 16(5):973-7. PubMed ID: 7479344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central effects of neuropeptide FF on intestinal motility in naive and morphine-dependent rats.
    Gelot A; Fioramonti J; Zajac JM; Bueno L
    Neuropeptides; 1995 Nov; 29(5):245-50. PubMed ID: 8587659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.